Release Date: 04/12/18 14:21 Summary: Compulsory Acquistion Notice and IER Price Sensitive: Yes Download Document 5.52MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%